The Development of a Skin Cancer Classification System for Pigmented Skin Lesions Using Deep Learning

by Shunichi Jinnai, Naoya Yamazaki, Yuichiro Hirano, Yohei Sugawara, Yuichiro Ohe, Ryuji Hamamoto
Published 2020-07-01

The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report

by Kazushi Yoshida, Yutaka Fujiwara, Yasushi Goto, Takashi Kohno, Akihiko Yoshida, Koji Tsuta, Yuichiro Ohe
Published 2018-04-01

Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease.

by Chihiro Udagawa, Hidehito Horinouchi, Kouya Shiraishi, Takashi Kohno, Takuji Okusaka, Hideki Ueno, Kenji Tamura, Yuichiro Ohe, Hitoshi Zembutsu
Published 2019-01-01

Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer.

by Katsutoshi Ando, Fumiyuki Takahashi, Motoyasu Kato, Norihiro Kaneko, Tokuhide Doi, Yuichiro Ohe, Fumiaki Koizumi, Kazuto Nishio, Kazuhisa Takahashi
Published 2014-01-01

The Long Half-Life of Programmed Cell Death Protein 1 Inhibitors May Increase the Frequency of Immune-Related Adverse Events After Subsequent EGFR Tyrosine Kinase Inhibitor Therapy

by Yuki Shinno, MD, Yasushi Goto, MD, PhD, Mayu Ohuchi, Akinobu Hamada, Hiroshi Nokihara, Yasuhiro Fujiwara, Yuichiro Ohe
Published 2020-03-01

HSP90 inhibition overcomes EGFR amplification‐induced resistance to third‐generation EGFR‐TKIs

by Sho Watanabe, Yasushi Goto, Hiroyuki Yasuda, Takashi Kohno, Noriko Motoi, Yuichiro Ohe, Hiroyoshi Nishikawa, Susumu S. Kobayashi, Kazuyoshi Kuwano, Yosuke Togashi
Published 2021-03-01

Number of metastatic organs negatively affects the treatment sequence in patients with EGFR‐TKI failure

by Takaaki Mizuno, Hidehito Horinouchi, Sho Watanabe, Jun Sato, Ryo Morita, Shuji Murakami, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe
Published 2020-04-01

Mixed response to osimertinib and the beneficial effects of additional local therapy

by Yuki Shinno, Yasushi Goto, Jun Sato, Ryo Morita, Yuji Matsumoto, Shuji Murakami, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe
Published 2019-04-01

Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer

by Ryota Shibaki, Shuji Murakami, Yuki Shinno, Yuji Matsumoto, Yasushi Goto, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Noriko Motoi, Noboru Yamamoto, Yuichiro Ohe
Published 2019-04-01

Predictive relevance of lymphovascular invasion in T1 colorectal cancer before endoscopic treatment

by Kazuya Inoki, Taku Sakamoto, Hiroyuki Takamaru, Masau Sekiguchi, Masayoshi Yamada, Takeshi Nakajima, Takahisa Matsuda, Hirokazu Taniguchi, Shigeki Sekine, Yukihide Kanemitsu, Yuichiro Ohe, Yutaka Saito
Published 2017-12-01

Identification of biological properties of intralymphatic tumor related to the development of lymph node metastasis in lung adenocarcinoma.

by Keisuke Kirita, Genichiro Ishii, Rie Matsuwaki, Yuki Matsumura, Shigeki Umemura, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Koichi Goto, Hironobu Ohmatsu, Yuichiro Ohe, Kanji Nagai, Atsushi Ochiai
Published 2013-01-01

Nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer: study protocol for a multicentre randomised control...

by Takuhiro Yamaguchi, Tempei Miyaji, Yosuke Uchitomi, Eriko Satomi, Masanori Mori, Yoshihisa Matsumoto, Yuichiro Ohe, Tomoe Mashiko, Shigeki Umemura, Ayumi Okizaki, Naoko Kobayashi, Hiroya Kinoshita, Koichi Goto
Published 2020-11-01

Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions

by Chie Morita, Tatsuya Yoshida, Masayuki Shirasawa, Ken Masuda, Yuji Matsumoto, Yuki Shinno, Shigehiro Yagishita, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Noriko Motoi, Yasushi Yatabe, Yuichiro Ohe
Published 2021-09-01

Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study

by Saeka Egami, Hitoshi Kawazoe, Hitoshi Kawazoe, Hironobu Hashimoto, Ryuji Uozumi, Toko Arami, Naomi Sakiyama, Yuichiro Ohe, Hideo Nakada, Tohru Aomori, Tohru Aomori, Shinnosuke Ikemura, Shinnosuke Ikemura, Koichi Fukunaga, Masakazu Yamaguchi, Tomonori Nakamura, Tomonori Nakamura
Published 2021-05-01

Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma

by Yusuke Okuma, Yasushi Goto, Fumiyoshi Ohyanagi, Kuniko Sunami, Yoshiro Nakahara, Satoru Kitazono, Keita Kudo, Yuichi Tambo, Shintaro Kanda, Noriko Yanagitani, Atsushi Horiike, Hidehito Horinouchi, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Makoto Nishio, Yuichiro Ohe, Yukio Hosomi
Published 2020-10-01

Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study

by Nobukazu Fujimoto, MD, PhD, Morihito Okada, MD, PhD, Takashi Kijima, MD, PhD, Keisuke Aoe, MD, PhD, Terufumi Kato, MD, Kazuhiko Nakagawa, MD, PhD, Yuichiro Takeda, MD, PhD, Toyoaki Hida, MD, PhD, Kuninobu Kanai, MD, PhD, Jun Hirano, MPharm, Yuichiro Ohe, MD, PhD
Published 2021-03-01

Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR)

by Hiroshi Tanaka, Hiroyuki Suzuki, Junichi Shimizu, Daichi Fujimoto, Toshiyuki Kozuki, Osamu Hataji, Kyoichi Okishio, Ryo Morita, Haruhiro Saito, Hiroshi Sakai, Young Hak Kim, Makiko Yomota, Makoto Nishio, Keisuke Aoe, Osamu Kanai, Toru Kumagai, Kayoko Kibata, Hiroaki Tsukamoto, Satoshi Oizumi, Keiko Mizuno, Takeshi Masuda, Takashi Haku, Isamu Okamoto, Hirotoshi Hoshiyama, Nobumichi Yada, Yuichiro Ohe
Published 2020-10-01

Proteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patients.

by Fredrik Nyberg, Atsushi Ogiwara, Chris G Harbron, Takao Kawakami, Keiko Nagasaka, Sachiko Takami, Kazuya Wada, Hsiao-Kun Tu, Makiko Otsuji, Yutaka Kyono, Tae Dobashi, Yasuhiko Komatsu, Makoto Kihara, Shingo Akimoto, Ian S Peers, Marie C South, Tim Higenbottam, Masahiro Fukuoka, Koichiro Nakata, Yuichiro Ohe, Shoji Kudoh, Ib Groth Clausen, Toshihide Nishimura, György Marko-Varga, Harubumi Kato
Published 2011-01-01

Usefulness of Simple Original Interstitial Lung Abnormality Scores for Predicting Radiation Pneumonitis Requiring Steroidal Treatment After Definitive Radiation Therapy for Patient...

by Tairo Kashihara, MD, PhD, Yuko Nakayama, MD, PhD, Kimiteru Ito, MD, PhD, Yuko Kubo, MD, Kae Okuma, MD, PhD, Satoshi Shima, MD, Satoshi Nakamura, PhD, Kana Takahashi, MD, PhD, Koji Inaba, MD, PhD, Naoya Murakami, MD, PhD, Hiroshi Igaki, MD, PhD, Yuichiro Ohe, MD, PhD, Masahiko Kusumoto, MD, PhD, Jun Itami, MD, PhD
Published 2021-01-01

Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma

by Kazuhiko Nakagawa, MD, PhD, Takashi Kijima, MD, PhD, Morihito Okada, MD, PhD, Masahiro Morise, MD, PhD, Motoyasu Kato, MD, PhD, Katsuya Hirano, MD, Nobukazu Fujimoto, MD, PhD, Mitsuhiro Takenoyama, MD, PhD, Hiroshi Yokouchi, MD, PhD, Yuichiro Ohe, MD, PhD, Toyoaki Hida, MD, PhD, Keisuke Aoe, MD, PhD, Takumi Kishimoto, MD, PhD, Masato Hirokawa, MSc, Hironori Matsuki, MEng, Yutaro Kaneko, BSc, Taketo Yamada, MD, PhD, Chikao Morimoto, MD, PhD, Masayuki Takeda, MD, PhD
Published 2021-06-01